Leadership Overview
AWH has 4 executives leading key functions including strategy, financial oversight, operational management, and corporate governance.
Focused on expanding the reach of premium cannabis products, [[AWH]] maintains a commitment to high-quality cultivation and distribution across the United States. This leadership team drives the company mission to provide consistent, reliable consumer packaged goods through innovative manufacturing and retail excellence.
Focused on expanding the reach of premium cannabis products, [[AWH]] maintains a commitment to high-quality cultivation and distribution across the United States. This leadership team drives the company mission to provide consistent, reliable consumer packaged goods through innovative manufacturing and retail excellence.
Leadership Roles at Ascend Wellness Holdings
Samuel Brill - Chief Executive Officer
Samuel Brill, the Chief Executive Officer at AWH, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the expansion of cannabis cultivation and retail footprints, the Chief Executive Officer ensures alignment between market demand and production capacity. This leadership role involves navigating complex regulatory landscapes while scaling the distribution of diverse brands like Ozone and SimplyHerb. By fostering partnerships and optimizing the supply chain, Samuel Brill directly impacts the company's competitive positioning within the United States cannabis market. Brill maintains a focus on sustainable growth and operational efficiency, ensuring that all manufacturing facilities meet rigorous quality standards. Through constant evaluation of market trends, the Chief Executive Officer secures the financial health and brand reputation of the enterprise, driving consistent value for stakeholders while maintaining a commitment to excellence in every consumer packaged good produced.
Roman Nemchenko - Chief Financial Officer
Roman Nemchenko, the Chief Financial Officer at AWH, manages the fiscal health and capital allocation strategies for the entire organization. Overseeing financial reporting, budgeting, and investor relations, the Chief Financial Officer ensures the company maintains a robust balance sheet to support ongoing cultivation and dispensary operations. This leadership role involves analyzing revenue streams from diverse product lines, including concentrates and edibles, to optimize profitability across all regional markets. By implementing rigorous financial controls and risk management frameworks, Roman Nemchenko directly impacts the company's ability to scale operations effectively. Nemchenko coordinates with the executive team to evaluate potential acquisitions and infrastructure investments, ensuring that every dollar spent aligns with the broader corporate mission. Ultimately, the Chief Financial Officer secures the long-term financial stability of the firm, providing the necessary resources to sustain market leadership in the competitive cannabis industry.

Frank Perullo - Founder & President & Director
Frank Perullo, the Founder & President & Director at AWH, architects the foundational business model and guides the strategic direction of the company. Overseeing corporate governance and high-level board initiatives, the Founder & President & Director ensures that the organization remains true to the core mission of providing premium cannabis products. This leadership role involves cultivating key industry relationships and shaping the long-term growth trajectory of the brand portfolio. By providing executive oversight on major policy decisions and market expansion efforts, Frank Perullo directly impacts the company's influence within the national cannabis sector. Perullo works closely with the leadership team to integrate new brands and manage the complexities of a multi-state operation. Ultimately, the Founder & President & Director secures the company's legacy and future potential, maintaining a focus on innovation and market leadership while navigating the evolving regulatory environment of the United States.

Michael McLaughlin - Chief Operations Officer
Michael McLaughlin, the Chief Operations Officer at AWH, directs the daily manufacturing, cultivation, and distribution activities across all facilities. Overseeing the end-to-end supply chain, the Chief Operations Officer ensures that products like flowers, vapes, and pre-rolls reach retail locations with maximum efficiency and quality. This leadership role involves managing complex logistics and operational workflows to maintain consistent inventory levels for brands such as Miss Grass and Binske. By optimizing production processes and implementing advanced cultivation techniques, Michael McLaughlin directly impacts the company's ability to meet consumer demand across the United States. McLaughlin collaborates with regional managers to streamline dispensary operations, ensuring a seamless customer experience. Through the continuous improvement of operational protocols, the Chief Operations Officer drives productivity and reduces waste, ultimately strengthening the company's market presence and operational resilience in a rapidly evolving industry.
Explore Leadership Teams in Manufacturing
Dr. Reddy's is a leading manufacturer and supplier of high-quality, affordable Active Pharmaceutical Ingredients (APIs) aimed at generic formulations manufacturers worldwide. With a portfolio of over 250 APIs available in more than 80 countries, the company focuses on sustainability and regulatory compliance to ensure access to affordable medicines. Their services include strategic alliances, discovery and CDMO, and advanced research capabilities, making them a trusted partner in the pharmaceutical industry. Dr. Reddy's commitment to innovation and quality positions them as a preferred partner for pharma companies globally.
Company Leadership
SC
DL

Novo Nordisk is a global pharmaceutical company focused on developing innovative medicines and drug delivery systems for the treatment of serious chronic diseases. The company specializes in biological medicines for diabetes, obesity, and rare blood and endocrine disorders, combining scientific research with advanced manufacturing capabilities to improve patient access to treatment worldwide. Through continuous innovation, large-scale production, and operational excellence, Novo Nordisk is committed to expanding access to life-changing therapies and improving health outcomes for people living with chronic conditions.
Company Leadership PG
KO
KK
VN
USV Private Limited is an Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, India. USV Limited was established in 1961.
Company Leadership

AM
Ferring Pharmaceuticals is a specialty biopharmaceutical group dedicated to helping individuals build families and improve their quality of life. The company specializes in reproductive medicine, maternal health, gastroenterology, and urology, with a strong focus on innovative therapies. With over 50 years of experience, Ferring develops treatments aimed at supporting mothers and babies from conception to birth. Their commitment to research and development drives the creation of life-changing solutions for patients worldwide.
Company Leadership ED

SK